<bill session="116" type="h" number="2064" updated="2022-11-01T19:02:21Z">
  <state datetime="2019-04-03">REFERRED</state>
  <status>
    <introduced datetime="2019-04-03"/>
  </status>
  <introduced datetime="2019-04-03"/>
  <titles>
    <title type="display">To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.</title>
    <title type="official" as="introduced">To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001080"/>
  <cosponsors>
    <cosponsor bioguide_id="N000181" joined="2019-04-03"/>
  </cosponsors>
  <actions>
    <action datetime="2019-04-03">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-04-03" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-04-03">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-04-03">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-04-04">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-05-21">
      <text>Subcommittee Hearings Held.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Hearings, Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="2113" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Consumer affairs"/>
    <term name="Government information and archives"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Inflation and prices"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-01-04T15:10:29Z" status="Introduced in House">This bill requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.</summary>
</bill>
